Small Cap U.S. Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Nov 20, 2024

Discover small cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

829 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TCBP

TC Biopharm (Holdings)
US$0.63-31.6%-99.4%US$326.3kn/aPB0.3xn/an/a

CYCC

Cyclacel Pharmaceuticals
US$0.37-17.5%-91.1%US$737.6kUS$1.00PS9.9xE76.3%n/a

SPRC

SciSparc
US$0.240.6%-96.8%US$857.1kn/aPB0.1xE63.0%n/a

PBM

Psyence Biomedical
US$0.05-11.0%-99.7%US$876.6kn/aPE-0.02xn/an/a

REVB

Revelation Biosciences
US$0.76-16.6%-96.2%US$1.3mUS$12.75PB0.5xS90.1%n/a

ZVSA

ZyVersa Therapeutics
US$1.15-8.0%-96.0%US$1.3mUS$20.00PB0.2xn/an/a

ENTO

Entero Therapeutics
US$0.40-36.4%-92.0%US$1.3mUS$36.00PB0.2xE6.3%n/a

SXTC

China SXT Pharmaceuticals
US$0.38-16.7%-78.5%US$1.3mn/aPB0.1xn/an/a

TFFP

TFF Pharmaceuticals
US$0.37-77.8%-95.0%US$1.4mn/aPS1.1xn/an/a

CYTO

Altamira Therapeutics
US$0.446.1%-92.6%US$1.4mUS$5.29PB0.2xE-5.9%n/a

NBSE

NeuBase Therapeutics
US$0.38-7.8%-90.2%US$1.4mn/aPB0.1xn/an/a

DRMA

Dermata Therapeutics
US$1.16-5.7%-89.1%US$1.6mUS$6.00PB0.4xE-9.7%n/a

SXTP

60 Degrees Pharmaceuticals
US$0.92-6.1%-86.5%US$1.7mUS$5.50PS3.7xE1.0%n/a

YCBD

cbdMD
US$0.450.04%-31.3%US$1.7mUS$2.00PB0.6xE107.9%n/a

ALLR

Allarity Therapeutics
US$1.19-17.9%-99.6%US$1.8mn/aPB0.1xE8.1%n/a

SLXN

Silexion Therapeutics
US$0.23-7.7%-97.9%US$1.9mUS$1.00n/aE-9.7%n/a

SONN

Sonnet BioTherapeutics Holdings
US$2.92-5.2%-73.6%US$2.0mUS$240.00PS34xn/an/a

SHPH

Shuttle Pharmaceuticals Holdings
US$0.90-19.1%-77.6%US$2.0mn/aPE-0.2xn/an/a

AKAN

Akanda
US$1.372.1%-96.2%US$2.0mn/aPB0.4xn/an/a

GRI

GRI Bio
US$0.64-27.4%-99.1%US$2.0mUS$12.00PB0.5xE-4.5%n/a

SLRX

Salarius Pharmaceuticals
US$1.40-0.7%-72.5%US$2.0mUS$26.00PB0.8xE-56.1%n/a

SCPX

Scorpius Holdings
US$0.67-10.4%-99.1%US$2.1mUS$5.00PB0.07xE75.2%n/a

BDRX

Biodexa Pharmaceuticals
US$3.85-20.6%-94.0%US$2.1mUS$199.78PS21.3xS-70.6%n/a

QLGN

Qualigen Therapeutics
US$3.87-6.1%-88.6%US$2.1mn/aPE-0.3xn/an/a
Page 1 of 35
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.